The model B of MDA provided the best performance and identified CA with 100% sensitivity and 81% accuracy. When used prospectively it showed 100% sensitivity, both in the Padua (88% accuracy) and in the Reggio Emilia series (90% accuracy). However, at both institutions most patients with idiopathic hyperaldosteronism (IHA) were also detected. CONCLUSIONS Thus, although developed from patients with confirmed Conn's adenoma, a strategy based on multivariate discriminant analysis can be used prospectively for accurate screening for primary aldosteronism. Furthermore, it was proven to be accurate and applicable to patients tested with similar modalities at a different institution. Although this approach did not provide a clear-cut discrimination of Conn's adenoma from idiopathic hyperaldosteronism, it may avoid unnecessary and costly further testing in patients with a low probability of primary aldosteronism.
overlap of results none proved to be sufficiently reliable and accurate to be used alone (Streeten et al., 1979; Fontes et al., 1991) . As an example, despite the fact that normokalaemic primary aldosteronism was recognized more than three decades ago (Conn et al., 1965 (Conn et al., , 1966 , and hypokalaemia is absent in 7 to 38% of reported PA patients (Weinberger et al., 1979; Bravo, 1986) , serum potassium is frequently used to screen for PA. Of the other widely used tests, plasma renin activity (PRA) is low also in 40% of ('low-renin') essential hypertensives, and plasma aldosterone high also in cases of secondary aldosteronism (Weinberger et al., 1979; Bravo, 1986; Gordon et al., 1987; Gleason et al., 1993) .
To overcome these problems, the measurement of PRA and aldosterone under strictly controlled conditions of sodium intake, and/or after dynamic testing, such as standing up, diuretic administration, saline infusion, or captopril administration has been proposed (Streeten et al., 1979; Mantero et al., 1981; Lyons et al., 1983; Holland et al., 1984; Iwaoka et al., 1993) . Whilst diagnostic accuracy might be enhanced with such procedures, they are costly, time-consuming, and moreover fraught with false-negative and positive responses; the latter precluded a clear-cut differentiation of individual CA patients from other hypertensives. More recently, it has been suggested that oxygenated metabolites of corticosterone (Kem et al., 1985) and cortisol can be relatively specifically increased in CA (Ulick et al., 1993; Blumenfeld et al., 1994) , but their measurement is not readily available to most laboratories.
In view of the importance of considering at the same time aldosterone and PRA, assessment of their ratio has also been put forward and exploited for the screening of PA (Hiramatsu et al., 1981; Hamlet et al., 1985; Lins & Adamson, 1986; Gordon, 1995) . Although an abnormally high ratio strongly indicates further testing, the facts that firstly false-negative ratios were found in a considerable percentage of PA patients (Weinberger & Fineberg, 1993) , secondly similar ratios can derive from quite different plasma renin and aldosterone values and finally a high ratio can simply be due to a low PRA, has hampered this approach. It was thereafter proposed that the ratio could retain its value only if the absolute plasma level of aldosterone is high, either under baseline (Weinberger & Fineberg, 1993) or after a single dose of captopril (Lyons et al., 1983) . Thus, the potential usefulness of a multivariate approach started to be appreciated. In fact, by combining the saline suppression test with a low stimulated PRA, a fasting serum potassium concentration below 3·5 mmol/l and lack of depressor response to the administration of saralasin, Streeten et al. (1979) reported a high (95%) sensitivity for the screening of PA although they undertook no formal multivariate analysis.
We hypothesized that a multivariate statistical approach by combining the information from several biochemical tests may provide an accuracy higher than that of conventional univariate analyses, for the screening of CA patients. To test this hypothesis we used an approach based on discriminant analysis, which is particularly appropriate to this end. Based on measurements obtained in patients unequivocally attributed to distinct diagnostic groups, this statistical technique allows to develop a (discriminant) function which assigns new patients to the correct diagnosis group (Kleinbaum et al., 1988) . Thus, we investigated at first retrospectively for developing the function, and then prospectively to test its accuracy, a large proportion of hypertensives referred to two specialized hypertension centres.
Patients and methods
A total of 574 Caucasian patients were investigated. Of them, 206 (111 female and 95 male, aged 49 Ϯ 14 years) were patients referred to the Clinica Medica of the University of Padua between January 1992 and December 1995 for evaluation of high blood pressure, were retrospectively studied. Fortyeight additional patients were studied prospectively at the same institution from December 1995 to November 96 for the validation of the statistical model. In addition, 320 hypertensives referred to the Divisione di Medicina Interna 4 of the Hospital of Reggio Emilia, Italy were assessed. The reasons for referral were: onset of hypertension at a young age, and/or hypertension refractory to conventional medical therapy, and/or spontaneous or diuretic-induced hypokalaemia, and/or high plasma aldosterone, and/or low PRA, and/or incidental discovery of an adrenal mass. All patients underwent a complete biochemistry profile at the time of admission, which included measurements of baseline and captopril-stimulated PRA and aldosterone (Bravo, 1993) ; the latter were undertaken only after the hypokalaemia, if present on admission, had been corrected with K þ supplementation. Most of the individuals were not taking drugs at the time of the study; where necessary, any antihypertensive agents were withdrawn at least 2 weeks (median 4 weeks) and spironolactone at least 6 weeks prior to investigation. In 33 patients, in whom treatment could not be withdrawn for ethical reasons, a calcium entry blocker was allowed at the minimum dosage required to achieve blood pressure control, since chronic treatment with these agents only slightly increased plasma renin activity (Mantero et al., 1986) and did not significantly alter aldosterone levels Bursztyn et al., 1988) . All individuals ate the normal diet of our hospital (range 100-200 mmol/day sodium, 50-75 mmol/day potassium intake). The study design and procedures followed the guidelines of our university for clinical studies and each patient gave an informed consent.
PA and essential hypertension (EH) were diagnosed as previously reported (Rossi et al., 1993 (Rossi et al., , 1994 , based on all clinically required tests, which included measurements of plasma catecholamines, renal vein renin studies and digital subtraction angiography in selected cases. To identify the aetiology of PA, adrenal Computed Tomography (n ¼ 62), Magnetic Resonance Imaging (MRI) (n ¼ 39), dexamethasonesuppressed adrenocortical scintigraphy (n ¼ 15), saline suppression test, Southern blotting for glucocorticoid-remediable aldosteronism, and adrenal vein sampling (n ¼ 35) were performed when clinically required. This latter procedure was carried out in all cases, where MRI and/or CT could not unequivocally visualize a CA. Idiopathic Hyperaldosteronism was considered to be present when PRA is below the normal range and unresponsive to captopril stimulation, increased plasma aldosterone level which failed to normalize with a saline infusion (Streeten et al., 1979; Holland et al., 1984) and/or an aldosterone/PRA ratio >30 (Gordon, 1995) and negative MRI and/or CT scan, and no evidence of unilateral overproduction of aldosterone at adrenal vein sampling and/or dexamethasone-suppressed adrenocortical scintigraphy were found (Rossi et al., 1993 (Rossi et al., , 1995a . Adrenal CT scan and MRI were performed as reported (Rossi et al., 1993) , with a third generation instrument (Tomoscan Lx-Philips, Einthoven, The Netherlands) and with a 1·5 Tesla Gyroscan S15 (Philips, Einthoven, The Netherlands), respectively. Sampling of adrenal venous and infrarenal inferior vena cava blood (AVS) for measurement of plasma aldosterone and cortisol was performed, as previously described (Rossi et al., 1993 (Rossi et al., , 1994 . The criteria for the definition of a positive CT, MRI and dexamethasone-suppressed adrenocortical scintigraphy and AVS were already reported in detail (Rossi et al., 1993) .
Samples for PRA and aldosterone
Between 0800 h and 0900 h, after the subjects had been fasting overnight and lying quietly in the supine position for at least one hour, venous blood was collected into prechilled tubes containing 200 ml Na 2 EDTA with the utmost care to avoid any stress to the patient. Blood samples were taken again 45 minutes after the oral administration of 50 mg captopril. The patients remained supine throughout the test (Iwaoka et al., 1990) for the sake of standardization and to exclude the risk of possible symptomatic orthostatic hypotension, which was previously occasionally seen. Samples were centrifuged immediately at 3000 × g at 4ЊC for 15 minutes and the supernatant was collected and frozen at ¹20ЊC until assayed. PRA was measured by a commercially available kit (Ares Serono, Milan, Italy; supine normal values with a daily sodium intake of 100-200 mmol: 0.51-2.64 ng Angiotensin I/ml/h) as generation of angiotensin I after incubation for 2 hours at 37ЊC, pH 6.0. Plasma aldosterone (normal values, with a daily sodium intake of 100-200 mmol: 56-333 pmol/l) was measured by radioimmunoassay using a commercially available kit (Ares Serono, Milan, Italy).
Essential hypertensives were divided into normal-, low-and high-renin, as reported (Rossi et al., 1995b) .
Statistical analysis
For the retrospective development of the logistic model of discriminant analysis the original cohort of 206 patients was used. In this series the criteria used to diagnose CA were the following: biochemical demonstration of low PRA and elevated plasma aldosterone; morphological demonstration of the tumour (by CT and/or MRI); demonstration of unilateral overproduction of aldosterone at adrenal vein sampling and/or dexamethasone-suppressed scintigraphy; pathological diagnosis consistent with adenoma; demonstration of either normalization of blood pressure or of a marked improvement in hypertension after adrenalectomy; demonstration of a decrease in left ventricular mass, as assessed by echocardiography, after adrenalectomy.
In this series a cursory examination of the data, via normal quantile-quantile plots, showed strong evidence of nonnormality for the following variables: supine and captoprilsuppressed plasma aldosterone, and supine and captoprilstimulated PRA. Therefore, the methods most commonly used to derive classification rules, namely the linear and the quadratic discriminant analysis (Hanley & McNeil, 1982 Kleinbaum et al., 1988; Chambers & Hastie, 1991; Everitt & Dunn, 1991; Michie et al., 1994) , become invalid, because they require the assumption of a normal distribution. For this reason, to avoid artificial transformations of data, we performed a logistic discriminant analysis, i.e. a procedure independent of the distribution of explanatory variables.
The logistic function is:
. In this function the Probability (x) estimates the probability of CA. The models fitted are generalized linear models (GLM) with binomial family and logit link function (Mc Cullagh & Nelder, 1989) . Analyses have been carried out using the S-PLUS statistical package (Math-Soft, Seattle, WA, USA). In addition, one-way ANOVA, followed by Bonferroni post-hoc test, or Kruskall-Wallis test were performed to compare the features of the patients divided according to aetiology of the high blood pressure, as appropriate. It was decided a priori that variables to be entered in the model were those that jointly differed between patients with and without CA. A classical ROC (Receiver Operator Characteristics) curve analysis (Griner et al., 1981; Hanley & McNeil, 1982) was also carried out. A non-linear regression model (hyperbola) was fitted to the ROC data and the curves of the two MDA models and of the Aldo/PRA ratio were compared in terms of slope. In addition, the area under the curve (AUC) was calculated for each MDA model and for the Aldo/PRA ratio and compared for statistical significance according to the method of Hanley & McNeil (1982 .
Validation of the model
The logistic function developed, based on the retrospective discriminant analysis of the first 206 patients, was tested in 48 consecutive hypertensive patients (29 f. and 19 m., aged 51 Ϯ 13), who were studied between September 1995 and August 1996. In addition, it was applied to the 320 hypertensives (157 f. and 163 m., aged 49 Ϯ 12 years) investigated at the 'Divisione of Medicina Interna 4' of Reggio Emilia. In the latter patients the captopril test was carried out with similar modalities, but subjects were assessed between 0900 h and 1100 h while sitting. In these patients a saline suppression test (Streeten et al., 1979) was performed at the same time on a different day in order to confirm autonomous production of aldosterone according to Holland et al. (1984) . Patients with an aldosterone/PRA ratio >30 (Gordon et al., 1994) under baseline conditions and a plasma aldosterone levels >208 pmol/l after the saline suppression test were considered to have PA. The diagnosis of CA was thereafter made also in these subjects according to the criteria specified above.
Results
In the cohort of patients investigated retrospectively for development of the logistic function, CA was eventually diagnosed in 32 patients and ruled out in the remaining 174, according to the criteria reported above. The presence of an aldosterone-producing tumour was not only confirmed at surgery and pathology in 24 patients, but also supported by the demonstration of normalization or a marked decrease of blood pressure and left ventricular mass at echocardiography after adrenalectomy. In the remaining 8 patients, who refused surgery, it was proven conclusively by the results of CT and adrenal vein sampling and/or dexamethasone-suppressed 716 G. P. Rossi et al. ᭧ 1998 Blackwell Science Ltd, Clinical Endocrinology, 49, 713-723 
BMI, Body mass index; sPRA, supine plasma renin activity; cPRA, captopril-stimulated plasma renin activity; sALDO, supine plasma aldosterone; cALDO, captopril-suppressed plasma aldosterone; K þ , serum potassium level; BUN, blood urea nitrogen; K PRA, (cPRA ¹ sPRA); K Aldo, (sALDO ¹ cALDO); sALDO/sPRA ratio, (Aldo/PRA × 10 2 ).
adrenocortical scintigraphy (Rossi et al., 1993 (Rossi et al., , 1995a . Of the patients without CA, 19 were considered to have IHA, according to the aforementioned criteria (Rossi et al., 1993) , and the remaining 155 essential hypertension. Of the latter, 119 had normal-, 17 low-, and 19 high-renin essential hypertension. The demographical, biochemical and clinical features of the 206 patients studied divided into those with and without CA shown in Table 1 . Of interest, with a Na þ urinary excretion ranging between 88 and 155 mmol/day, serum K þ levels lower than 3.5 mmol/l were seen at the time of admission only in 41% of the patients with proven CA. Of the variables in Table 1 , the following jointly differed significantly ( p < 0·05) between the CA and non-CA groups: supine Plasma Renin Activity (sPRA), supine plasma Aldosterone (sALDO), captopril-suppressed plasma Aldosterone (cALDO) and serum potassium (K þ ). Therefore, they were used for the multivariate discriminant analysis. Some of these variables, which differed significantly between our two groups, were also tested for the purpose of the differentiation of CA from the remaining patients with ROC curve analysis (Hanley & McNeil, 1982 (Fig. 1, inset) .
Results of the discriminant analysis (DA)
The general function for the screening of CA, which estimates the probability of CA, is: . On the ordinate axis, the values from 0 to 1 indicate increasing probability of Conn's Adenoma and therefore the probability of absence of CA is: (1-probability of CA). Symbols: X Conn's adenoma; W Idiopathic Hyperaldosteronism; A Normal-renin EH; B Low-renin EH; K High-renin EH. The vertical broken line divides the 32 patients with CA from the rest of those without CA. With a cut-off of 5% (horizontal broken line) the multivariate model B provides the best performance, i.e. a 100% sensitivity, 77·6% specificity and overall correct classification rate (accuracy) of 80·7%. In the inset the result of a ROC (Receiver Operator Characteristics) curve analysis for the multivariate probability of CA with model A (X) and model B (B). Serum K þ (S), sPRA (V), sALDO (P) and the sALDO/sPRA ratio (A) are shown. The cut-off values for the multivariate probability were 4%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60% and 65%; for PRA: 0·30, 0·40, 0·50, 0·60, 0·70, 0·80 (ng Ang I/ml/hr); for sALDO: 125, 150, 200, 250, 300 (pmol/l); for sALDO/sPRA ratio: 1·5, 2, 2·5, 3, 4, 5, 10; for serum K þ : 3·0, 3·1, 3·2, 3·3, 3·4, 3·5 and 3·6 mmol/l.
Since sALDO and cALDO were found to be linearly related, based on the assumptions of the multivariate analysis they could not be included in the same model and therefore two different 3-variable models based on sPRA, K þ , and on either sALDO (Model A) or cALDO (Model B) were developed. Their coefficient values are shown in Table 2 ; as an example, the bx value for model B can be derived by the following:
The DA results for the screening of CA patients in the first sample of 206 patients are shown in Fig. 1 . The cut-off probability value was determined by a ROC curve analysis (Hanley & McNeil, 1982 , as shown on Fig. 1 (inset) . For the calculation of sensitivity, specificity and accuracy accomplished with this function a cut-off value of 0·05 was used. The results attained with a conventional univariate approach based on serum K þ , sPRA, sALDO, and with the sALDO/sPRA ratio are also shown in Fig. 1 (inset) in terms of ROC curve analysis. The logistic discriminant function not only identified correctly all CA patients (100% sensitivity), but also provided an overall correct classification rate (accuracy) of 81%. This resulted into a remarkable incremental value, as shown by the shift to the left of the ROC curve, as compared to all univariate tests and also to the sALDO/sPRA ratio. Statistical comparison of the ROC curves of both model B and A with the Aldo/PRA ratio revealed a highly significant difference (P < 0·002) when either the slopes or the AUC were taken into account. In this series with a 15·5% prevalence of CA the positive predictive value (Griner et al., 1981) of model A and B at a cut-off value of 0·05 was 37% and 45%, respectively.
Prospective validation of the model
In the second cohort of 48 consecutive hypertensive patients PA was diagnosed in 11 (23%) 6 of whom had CA, essential hypertension in 33, renoparenchymal in 2, and renovascular hypertension in the 2 remaining patients. The two logistic function models developed based on the discriminant analysis of the first cohort of 206 patients were applied to these patients and gave the results shown in Table 3 . All patients with CA and 36 of the 42 without CA were identified correctly, and therefore the overall accuracy was 83·3% and 87·5%, with model A and B, respectively.
Among the 320 hypertensives of the Reggio Emilia cohort, 11 were diagnosed with and 309 without CA. Of the latter, 8 were considered to have IHA and 301 EH. As compared to the patients without, those with CA had significantly lower serum K þ (3·2 Ϯ 0·6 mmol/l vs. 3·9 Ϯ 0·3, P < 0·0001), and supine (0·14 Ϯ 0·08 ng Ang I/ml/h vs. 0·98 Ϯ 1·01, P < 0·0001) and captopril-stimulated PRA (0·15 Ϯ 0·10 vs. 2·80 Ϯ 3·23, P < 0·0001), and higher baseline (919 Ϯ 342 pmol/l vs. 478 Ϯ 247, P < 0·0001) and captopril-suppressed ALDO (930 Ϯ 342 vs. 314 Ϯ 181, P < 0·0001). The results of the MDA applied to these patients and the ROC analysis comparing model A and B are shown in Table 3 and Fig. 2 . In this series with a 3·6% prevalence of CA the positive predictive value (Griner et al., 1981) of model A and B at a cut-off value of 0·05 was 10% and 26%, respectively.
Discussion
Secondary forms of hypertension are uncommon but their identification, and particularly that of PA due to a unilateral adrenal overproduction of aldosterone, is of utmost importance from the therapeutic standpoint. Removal of an aldosteroneproducing tumour (or of primary unilateral adrenal hyperplasia) not only provides long-term cure of both hypokalemia and aldosteronism and thereby obviates a lifetime commitment to costly antihypertensive therapy in over 70% of the patients 718 G. P. Rossi et al. ᭧ 1998 Blackwell Science Ltd, Clinical Endocrinology, 49, 713-723 
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Abbreviations as in Table 1 . (Favia et al., 1992; Gleason et al., 1993) , but also may render resistant hypertension sensitive to antihypertensive agents (Bravo et al., 1988) . In addition, more favourable regression of left ventricular hypertrophy in surgically as compared to medically treated CA patients with similar blood pressure reduction was seen during long term follow-up (Bravo, 1986; Rossi et al., 1996) . Thus, a thorough diagnostic approach is justified, particularly in younger patients or those with severe and/or refractory hypertension, where the benefits of identifying an underlying cause are prominent. Identification of CA can be unduly difficult even with the use of available improved laboratory methods and imaging techniques (Fontes et al., 1991) . The present study is the largest ever performed for the screening of CA and was carried out on clinical series of referred hypertensives with a high pre-test likelihood of PA. The latter cause of hypertension was eventually identified in about 25% of them based on the use of the most sensitive, biochemical and imaging tests of the adrenal gland available (Rossi et al., 1993 (Rossi et al., , 1995a . Most of these patients had CA, as confirmed, both surgically and pathologically as well as by the amelioration of their hypertension after adrenalectomy. However, due to the overlapping of values between with EH patients (Table 1) , no single biochemical test, such as serum K þ , sPRA, sALDO, or the sALDO/sPRA ratio, identified such CA patients unambiguously (Fig. 1, inset) , in keeping with the data of the literature (Weinberger et al., 1979; Bravo et al., 1983; Vaughan et al., 1989; Young et al., 1990; Bravo, 1994) , as recently excellently reviewed (Vallotton, 1996) . Although we cannot rule out the possibility that the calcium antagonists, used in a small proportion of patients, due to their slight increase of PRA and no effect on aldosterone (Mantero et al., 1986) , might have worsened the diagnostic performance of the sALDO/sPRA ratio, this seems unlikely since under chronic administration the effect of these agents was negligible Bursztyn et al., 1988) . It is worth underlining that in the same series the logistic MDA, based on sPRA, cALDO, and serum K þ , (model B), provided a 100% sensitivity, and a good specificity and overall accuracy, when used both retrospectively and prospectively (Table 3) . Of interest, model B performed better than model A in terms of specificity (77·6% vs. 68·4%), likely because of the captopril-induced decrease of falsely elevated plasma aldosterone levels (Iwaoka et al., 1993) . Model B gave an even better result in a large cohort of hypertensives investigated at Reggio Emilia (Fig. 2) , probably due to the fact that the baseline biochemical measurements and the captopril test were carried out in the sitting position in this series. The lower positive predictive value with both models in the Reggio Emilia, as compared to the Padua series is obviously due to the lower prevalence of PA at this general hospital.
In this study the captopril test was performed with patients in the supine posture (Iwaoka et al., 1993) , while it might be argued that blood sampling after a period of deambulation increases the sensitivity of the plasma aldosterone/PRA ratio, due to the lack of postural stimulation of PRA in PA patients (Opocher et al., 1993) . It must be pointed out, however, that the response of aldosterone to postural stimulation is quite variable Fontes et al., 1991) leading investigators to consider this test invalid in as many as one third of carefully studied PA patients (Fontes et al., 1991) . Furthermore, the captopril test has been performed with either 25 or 50 mg of the drug administered for one week (Mantero et al., 1981) , or as a single dose, to patients kept standing, seated (Lyons et al., 1983) , or supine (Iwaoka et al., 1993) . To our knowledge, no study has established beyond doubts the superiority of one protocol over the others. Thus, although the conclusions of this study might not apply to patients investigated under quite different conditions, the fact that excellent sensitivity, specificity, and accuracy were obtained also in a large series of patients studied in the sitting position at another institution with a much lower prevalence of PA (Fig. 2) , lends support to the practical usefulness of this approach.
More than two decades ago the Glasgow group proposed a quadric analysis based on eight variables for the preoperative distinction between PA patients with and without CA (Ferris et al., 1970 (Ferris et al., , 1978 . This analysis was thereafter extended to the differentiation of IHA from EH with the application of Mahalanobis distance to several combinations of variables, which surprisingly enough, did not include PRA and aldosterone levels (McAreavey et al., 1983) . The fact that no clear-cut differentiation of the two conditions was achieved led those investigators to put forward the hypothesis of a similarity of EH and IHA (McAreavey et al., 1983) and to exclude the usefulness of their strategy for the purpose of identifying PA patients. A further refinement of a multivariate approach was proposed by Iwaoka et al., who used the captopril test and a quadratic discriminant function for the simultaneous screening of PA and renovascular hypertension (Iwaoka et al., 1993) . As compared to those studies, which were carried out retrospectively on much smaller series of PA patients, the present approach has several advantages. First, no transformation of the data is required, since the logistic function can accommodate variables not normally distributed. Second, the usefulness of our models was validated prospectively (Table 3) ; third, it was also shown to reward a high diagnostic accuracy in patients studied under similar conditions at a different institution (Fig. 2) ; fourth, it was found to translate into a significant incremental gain as compared to the widely used aldo/PRA ratio. Finally, the logistic function developed provides a straightforward individual estimate of the probability of having CA in each patient. Plotting the results thereafter allows for a differentiation of the patients of with and without CA (Figs 1 and 2) . Furthermore, integration of this value with remaining clinical information may enable clinicians to decide whether to proceed with further costly investigations in each individual patient.
Of interest, although the vast majority of our CA patients were correctly identified with the multivariate approach, a number of false positives, which mainly consisted of patients with IHA, were observed (Fig. 1) . Thus, although developed starting from a population with undoubtedly proven CA, our MDA approach detected IHA as well, i.e. resulted to be accurate for the screening of PA (Figs 1 and 2) .
It might be proposed that discrimination of CA and IHA could also be attained with a MDA approach similar to that described in this study. In our experience, which is fully consistent with previous findings (McAreavey et al., 1983) , this was not the case, even when a model specifically developed to this end (data not shown) was used. However, any attempt to distinguish CA from IHA solely on biochemical ground is likely to be a purely academic exercise, since the final arbiter to solve the dilemma between a CA and bilateral hyperplasia is the localization of the lesion by imaging techniques and adrenal vein sampling followed by the classic 'gold standards' of adrenal pathology and normalization of blood pressure and aldosterone levels at follow-up. It should also be considered that even though the differentiation between CA and IHA is often unambiguous, a continuum exists between a unilateral tumour and bilateral hyperplasia (Gleason et al., 1993; Weinberger & Fineberg, 1993) . In this study, approximately 50% of the patients with IHA had a high probability of CA, although we could not detect an adrenal tumour by CT and MRI, and/or unilateral overproduction of aldosterone at adrenal vein sampling. Accordingly, the possibility that these patients might harbour a small (micro) adenoma or unilateral adrenal hyperplasia can not be ruled out with certainty with the available technology and therefore close follow-up study of these subjects is ongoing.
Identification of a small adenoma (or of unilateral hyperplasia), which can be cured by surgery, usually requires adrenal vein sampling (Scoggins et al., 1972; Nicolis et al., 1972; Weinberger et al., 1979; Geisinger et al., 1983; Blevins & Wand, 1992; Rossi et al., 1995a ), a procedure not totally devoid of the risk of adrenal vein rupture (Scoggins et al., 1972; Nicolis et al., 1972; Geisinger et al., 1983; Blevins & Wand, 1992; Rossi et al., 1993) even when adrenal phlebography is avoided, which therefore should be reserved to patients with a high pre-test probability of CA. We think that the information provided by the strategy described in the present study can be useful for stratifying PA patients for their pre-test probability of CA and therefore for the selection of those to be investigated with adrenal vein sampling.
It must be acknowledged that this study has the following limitations. First, although the strategy and mathematical functions developed in this study have a general validity, calculation of new functions and coefficients may be needed for patients studied under different conditions and with different biochemical methods. Nevertheless, the results obtained on a series of consecutive hypertensives investigated with a similar protocol, but independently, lend support to its usefulness and feasibility. Second, since patients with CA and normal plasma aldosterone levels were occasionally seen, the fact that for developing retrospectively our statistical model we used very strict criteria for diagnosing CA (see above) might theoretically have led to a model with a low sensitivity, namely overlooking some cases of CA. However, the fact that our logistic model actually picked up also most cases of IHA makes this possibility unlikely.
In conclusion, our results show that strategies, such as the multivariate discriminant analysis of this study, which efficiently use the information contained in simple biochemical tests, can accomplish high sensitivity, specificity, and accuracy for the identification of primary aldosteronism in selected populations of hypertensives with a high pretest likelihood of this condition. Being based on biochemical tests that are widely available to most centres involved in the diagnosis and treatment of hypertensive patients, this strategy is feasible and affordable, and translates into a remarkable diagnostic incremental value as compared to univariate tests.
